Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Benefit and Risk of Oral Aspirin for Patients Who Have Unruptured Intracranial Aneurysm Combined With Cerebral Ischemia

NCT02846259 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT02846259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02846259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Benefit and Risk of Oral Aspirin for Patients Who Have Unruptured Intracranial Aneurysm Combined With Cerebral Ischemia
Lead sponsor
Beijing Tiantan Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2016
Completion date
December 31, 2019
Enrollment
2,135 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral ischemia, intracranial aneurysm